- Home
- XPEL vs IMTX Comparison
XPEL vs IMTX Comparison
Compare XPEL & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XPEL | IMTX |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | XPEL | IMTX |
|---|---|---|
| Price | $54.78 | $10.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $19.25 |
| AVG Volume (30 Days) | 204.9K | ★ 377.4K |
| Earning Date | 02-25-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $461,460,000.00 | $99,445,031.00 |
| Revenue This Year | $16.20 | N/A |
| Revenue Next Year | $11.28 | $19.39 |
| P/E Ratio | $31.90 | ★ N/A |
| Revenue Growth | ★ 10.29 | N/A |
| 52 Week Low | $24.25 | $3.30 |
| 52 Week High | $55.91 | $12.41 |
Technical Indicators
Market Signals| Indicator | XPEL | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 54.60 | 53.81 |
| Support Level | $50.35 | $9.63 |
| Resistance Level | $55.91 | $10.42 |
| Average True Range (ATR) | 1.84 | 0.68 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 60.25 | 82.50 |
Price Performance
Historical ComparisonAbout XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.